McMaster University’s medical school curriculum promotes compassionate, person-centered care by incorporating the views of persons with disabilities.

Neurobiological markers raise complex questions about what it means to be “at risk.”

What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early?

Which distinctions between minimally conscious states and vegetative states should clinicians consider?

Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy.

Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts.

Neuromodulation has ethical implications for self-identity and public communication of scientific findings.

The Bioethics Commission’s recommendations to include research participants with impaired consent capacity provide an ethical foundation for neuroscience.